EAST RUTHERFORD, N.J., April 27, 2012/PRNewswire/ -- Cambrex Corporation (NYSE: CBM) announced that first quarter 2012 financial results will be released on Thursday, May 3, 2012 after the market closes.
The Company will host a conference call to discuss the first quarter 2012 financial results.
First Quarter 2012 Earnings Conference Call
Friday, May 4, 2012 at 8:30 a.m. Eastern Time
1-800-499-7921 for U.S.
1-719-325-2412 for International
1-888-203-1112 for U.S.
1-719-457-0820 for International
Available through Friday, May 11, 2012
Available for 30 days following the conference call
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. We offer Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit www.cambrex.com.
SOURCE Cambrex Corporation